雷洛昔芬联合维生素D促进大鼠肩袖腱骨愈合
本研究在大鼠模型中评估雷洛昔芬(RLX)联合维生素D对肩袖腱骨愈合的影响,通过去卵巢诱导雌激素缺乏状态并修复肩袖。结果显示联合治疗可防止肱骨大结节局部骨密度下降,并改善组织学、生物力学及MRI的腱骨愈合指标。
要点
- 去卵巢大鼠中,RLX联合维生素D可防止肱骨大结节局部骨密度下降。
- RLX组组织学总分和失效载荷显著高于未用RLX组。
- micro-MRI显示RLX组腱骨界面信号更均匀、肌腱连续性更好。
核心结论
- 雷洛昔芬联合维生素D可防止去卵巢大鼠肱骨大结节局部骨密度下降,并促进肩袖腱骨愈合。
研究设计与样本
- controlled laboratory study,29只雌性大鼠(58侧肩)分为4组:对照组、仅去卵巢组、去卵巢+肩袖修复不用RLX组、去卵巢+肩袖修复用RLX联合维生素D组。
主要发现
- 仅去卵巢组终末体重(461.6 ± 47.3 g)显著高于对照组(338.5 ± 35.1 g),骨密度(0.25 ± 0.07 g/cm3)显著低于对照组(0.48 ± 0.05 g/cm3),P < .001。
- RLX组终末体重(369.6 ± 35.8 g)和骨密度(0.41 ± 0.08 g/cm3)与对照组无显著差异。
- RLX组组织学总分(8.50 ± 1.05)显著高于不用RLX组(4.83 ± 2.48)。
- 生物力学测试中,RLX组失效载荷(29.7 ± 9.1 N)显著高于不用RLX组(19.4 ± 8.8 N)。
- micro-MRI显示RLX组较不用RLX组呈现更均匀的低信号和更好的肌腱连续性。
临床怎么用
- 在雌激素缺乏状态下,雷洛昔芬联合维生素D可能作为促进肩袖腱骨愈合的潜在药物策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tearing and degeneration of the rotator cuff at the tendon-to-bone junction are common in adults aged ≥50 years. Few studies have reported on the relationship between estrogen and the rotator cuff enthesis. In addition to preventing bone loss, selective estrogen receptor modulators have been shown to improve tendon and muscle quality. PURPOSE: To evaluate the effects of raloxifene (RLX) and vitamin D on rotator cuff tendon-to-bone healing in a rat model. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 29 female rats (58 shoulders) were assigned to 4 groups: (1) control group, (2) ovariectomy (OVX)-only group, (3) no RLX group (OVX and rotator cuff repair [RCR]), and (4) RLX group (OVX, RCR, and RLX). Rats that did not undergo rotator cuff tear (RCT) surgery were divided into the control and OVX-only groups according to OVX surgery. Rats that underwent RCT surgery and RCR were divided into the no RLX and RLX groups according to RLX and vitamin D administration. An estrogen-deficient state was induced by OVX at 12 weeks of age. Bone mineral density (BMD) and trabecular bone characteristics were measured by micro-computed tomography, and healing of the tendon-to-bone junction was evaluated by biomechanical testing, histomorphometry, and micro-magnetic resonance imaging (MRI). RESULTS: The mean final body weight (BW; 461.6 ± 47.3 g) of the OVX-only group was significantly higher and BMD (0.25 ± 0.07 g/cm3) was significantly lower (P < .001) than the mean final BW (338.5 ± 35.1 g) and BMD (0.48 ± 0.05 g/cm3) of the control group. In contrast, the RLX group showed that the BW (369.6 ± 35.8 g) and BMD (0.41 ± 0.08 g/cm3) were not significantly different from the control group. The RLX group had a significantly higher histomorphometric total score (8.50 ± 1.05) than the no RLX group (4.83 ± 2.48). On biomechanical testing, the RLX group (29.7 ± 9.1 N) showed a significantly higher load to failure than the no RLX group (19.4 ± 8.8 N). On micro-MRI, the RLX group had a more homogeneous low signal and tendon continuity than the no RLX group. CONCLUSION: The combination treatment of RLX and vitamin D prevented a decrease in local BMD (greater tuberosity of the proximal humerus) and enhanced tendon-to-bone healing of the rotator cuff in a rat model. CLINICAL RELEVANCE: This study induced an estrogen-deficient state similar to the human postmenopausal state and used drugs that are actually being prescribed in a clinical situation.
引用
- Kim DM, Shim IK, Shin MJ, et al. A Combination Treatment of Raloxifene and Vitamin D Enhances Bone-to-Tendon Healing of the Rotator Cuff in a Rat Model. Am J Sports Med. 2020. PMID: 32574070. doi:10.1177/0363546520927015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。